Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD19-chimeric Antigen Receptor T Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06323525
What this trial is testing

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Who this might be right for
Non-hodgkin Lymphoma
Chinese PLA General Hospital 30
Very early researchLooking for participantsNCT06375161
What this trial is testing

Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.

Who this might be right for
B Cell Malignancies
Shanghai Tongji Hospital, Tongji University School of Medicine 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324889
What this trial is testing

An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Yihao Wang 24
Testing effectiveness (Phase 2)UnknownNCT03366350
What this trial is testing

Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 50
Early research (Phase 1)Looking for participantsNCT06777979
What this trial is testing

CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaRecurrent Acute Lymphoblastic LeukemiaRecurrent B Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 30
Testing effectiveness (Phase 2)Study completedNCT06588491
What this trial is testing

KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome

Who this might be right for
Stiff-Person SyndromeSPS
Kyverna Therapeutics 27
Early research (Phase 1)Active Not RecruitingNCT05797233
What this trial is testing

Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaB-Cell Chronic Lymphocytic LeukemiaLymphoma, B-Cell
National Cancer Institute (NCI) 58
Early research (Phase 1)Looking for participantsNCT06180174
What this trial is testing

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

Who this might be right for
B Cell LymphomaNon Hodgkin Lymphoma
Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Looking for participantsNCT06839976
What this trial is testing

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Who this might be right for
SLESystemic Lupus Erythematosus (SLE)CAR T Cell+4 more
Children's Hospital of Philadelphia 24
Early research (Phase 1)Not Yet RecruitingNCT07539610
What this trial is testing

Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors

Who this might be right for
B-Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 9
Testing effectiveness (Phase 2)Study completedNCT00924326
What this trial is testing

CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma

Who this might be right for
Primary Mediastinal B-cell LymphomaDiffuse, Large B-cell LymphomaDiffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma+1 more
National Cancer Institute (NCI) 43
Early research (Phase 1)Not Yet RecruitingNCT07725406
What this trial is testing

Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed or Refractory Multiple Myeloma (MM)
Weill Medical College of Cornell University 32
Early research (Phase 1)Study completedNCT04450069
What this trial is testing

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell LymphomasDiffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+9 more
Calibr, a division of Scripps Research 18
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Early research (Phase 1)Active Not RecruitingNCT06451159
What this trial is testing

KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Bruce Cree 10
Early research (Phase 1)Not Yet RecruitingNCT07383233
What this trial is testing

CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma

Who this might be right for
LymphomaCAR T Cell TherapyAcute Leukemia
Qi deng 18
Early research (Phase 1)Looking for participantsNCT07305116
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Not applicableUnknownNCT04546893
What this trial is testing

Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia

Who this might be right for
B-ALL
Hebei Senlang Biotechnology Inc., Ltd. 20
Very early researchLooking for participantsNCT06732232
What this trial is testing

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

Who this might be right for
RelapsedRefractoryMultiple Myeloma
Shanghai Cell Therapy Group Co.,Ltd 12
Early research (Phase 1)Looking for participantsNCT05535855
What this trial is testing

UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1

Who this might be right for
Acute Lymphoid LeukemiaAcute Lymphoblastic Leukemia
University of Colorado, Denver 29
Next Page